Quarterly report pursuant to Section 13 or 15(d)

Stock Options and Warrants

v3.22.1
Stock Options and Warrants
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock Options and Warrants

 

  8. Stock Options and Warrants

 

The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services, and for financing costs.

 

Options

 

Options vest according to the terms of the specific grant and expire from 2 to 10 years from date of grant. The weighted-average, remaining contractual life of employee and non-employee options outstanding at March 31, 2022 was 5.4 years. Stock option activity for the period January 1, 2022 up to March 31, 2022, was as follows:

               
    Options     Weighted
Avg. Exercise
Price
 
January 1, 2022     31,080,601     $ 0.17  
Granted            
Exercised            
Expired     (4,000,000 )     0.25  
March 31, 2022     27,080,601     $ 0.16  

 

 

The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of March 31, 2022 were as follows:

                       
    Outstanding Options   Exercisable Options

Option

Exercise Price

Per Share

  Shares   Life
(Years)
    Weighted
Average Exercise
Price
  Shares     Weighted
Average Exercise
Price
$0.02 - $0.24   22,305,551   5.9   $ 0.10   22,305,551   $ 0.10
$0.25 - $0.49   4,153,552   3.6     0.35   4,153,552     0.35
$0.50 - $0.99   471,052   2.1     0.85   471,052     0.85
$1.00 - $2.00   150,446   1.3     1.18   150,446     1.18
    27,080,601   5.4     0.16   27,080,601     0.16

 

During the three-month periods ended March 31, 2022 and 2021, the Company recognized compensation costs based on the fair value of options that vested of $0 and $10,000 respectively.

 

At March 31, 2022, the aggregate intrinsic value of the options outstanding at March 31, 2021 was $22,000.

 

Warrants

 

The following table summarizes certain information about the Company’s stock purchase warrants activity for the period starting January 1, 2022 up to March 31, 2022.

               
    Warrants     Weighted Avg.
Exercise Price
 
January 1, 2022     19,977,149     $ 0.04  
Granted     599,999       0.04  
Exercised     (825,000 )     0.03  
Expired     (99,999 )     0.09  
March 31, 2022     19,652,149     $ 0.04  

 

The weighted average exercise prices, remaining contractual lives for warrants granted, exercisable, and expected to vest as of March 31, 2022 were as follows:

                       
    Outstanding Warrants   Exercisable Warrants
Warrant Exercise Price Per Share   Shares   Life
(Years)
    Weighted Average Exercise Price   Shares     Weighted Average Exercise Price
$0.02 - $0.24   19,582,149   0.6   $ 0.04   19,548,816   $ 0.04
$0.25 - $0.49              
$0.50 - $1.00   70,000   2.1     0.80   70,000     0.80
    19,652,149   0.6     0.04   19,618,816     0.04

 

 

In the three-month period ending March 31, 2022, the Company issued warrants to purchase 599,999 shares of common stock in exchange for services. The warrants are exercisable at a price of $0.03 to $0.05, vesting up to one month from the date of grant, and expiring two to five years from the date of grant. Total fair value of these warrants at grant date was $24,000 using the Black-Scholes Option Pricing model with the following assumptions : life of 2 to 5 years; risk free interest rate of 0.73% to 2.14%; volatility of 193% to 245% and dividend yield of 0%. During the three-month period ended March 31, 2022, the Company recognized compensation costs based on the fair value of warrants that vested of $24,000.

 

At March 31, 2022, the aggregate intrinsic value of warrants outstanding was $68,000.